FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170592008> ?p ?o ?g. }

• W2170592008 endingPage "2614" @default.
• W2170592008 startingPage "2608" @default.
• W2170592008 abstract "Inhibition of 2,3-oxidosqualene:lanosterol cyclase (OSC), an enzyme in the cholesterol synthesis pathway, has the unique ability to inhibit cholesterol synthesis while simultaneously enhancing oxysterol synthesis. Our objectives were to determine, in vivo, if a novel OSC inhibitor reduced low-density lipoprotein (LDL) cholesterol and to define the mechanism(s) involved.Miniature pigs received the OSC inhibitor RO0717625 or placebo and a diet containing fat (34% of energy) and 400 mg per day of cholesterol. Treatment decreased plasma total cholesterol (-20%) and LDL cholesterol (-29%). Apolipoprotein B (apoB) kinetic parameters were determined. Very low-density lipoprotein (VLDL) apoB pool size decreased 22% because of inhibition of VLDL production (-43%). LDL apoB pool size decreased 22% because of a 1.5-fold increase in fractional catabolic rate (FCR). The increased FCR was associated with a 2-fold increase in hepatic LDL receptor mRNA. Hepatic total and microsomal cholesterol were reduced by 16% and 27%, respectively. Plasma lathosterol concentrations decreased 57%, reflecting inhibition of hepatic cholesterol synthesis. Treatment reduced plasma plant sterols and decreased postprandial cholesterol transport in chylomicrons.A novel OSC inhibitor, RO0717625, decreased VLDL and LDL apoB100 through decreased VLDL production and enhanced LDL clearance. Thus, OSC represents a potential therapeutic target for dyslipidemia." @default.
• W2170592008 created "2016-06-24" @default.
• W2170592008 creator A5009567259 @default.
• W2170592008 creator A5018121191 @default.
• W2170592008 creator A5036269593 @default.
• W2170592008 creator A5046009433 @default.
• W2170592008 creator A5055281543 @default.
• W2170592008 creator A5062832794 @default.
• W2170592008 creator A5071725615 @default.
• W2170592008 creator A5077211924 @default.
• W2170592008 creator A5078989315 @default.
• W2170592008 date "2005-12-01" @default.
• W2170592008 modified "2023-10-14" @default.
• W2170592008 title "A Novel Inhibitor of Oxidosqualene:Lanosterol Cyclase Inhibits Very Low–Density Lipoprotein Apolipoprotein B100 (ApoB100) Production and Enhances Low-Density Lipoprotein ApoB100 Catabolism Through Marked Reduction in Hepatic Cholesterol Content" @default.
• W2170592008 cites W1904828024 @default.
• W2170592008 cites W1908881400 @default.
• W2170592008 cites W1948251094 @default.
• W2170592008 cites W1963806825 @default.
• W2170592008 cites W1967286688 @default.
• W2170592008 cites W1982715024 @default.
• W2170592008 cites W2015241125 @default.
• W2170592008 cites W2023202905 @default.
• W2170592008 cites W2034790783 @default.
• W2170592008 cites W2050294137 @default.
• W2170592008 cites W2057327245 @default.
• W2170592008 cites W2062495925 @default.
• W2170592008 cites W2085156194 @default.
• W2170592008 cites W2085608855 @default.
• W2170592008 cites W2086024671 @default.
• W2170592008 cites W2095615927 @default.
• W2170592008 cites W2107020393 @default.
• W2170592008 cites W2125628785 @default.
• W2170592008 cites W2128660079 @default.
• W2170592008 cites W2136859326 @default.
• W2170592008 cites W2144050182 @default.
• W2170592008 cites W2150761911 @default.
• W2170592008 cites W4240735590 @default.
• W2170592008 doi "https://doi.org/10.1161/01.atv.0000189158.28455.94" @default.
• W2170592008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16210564" @default.
• W2170592008 hasPublicationYear "2005" @default.
• W2170592008 type Work @default.
• W2170592008 sameAs 2170592008 @default.
• W2170592008 citedByCount "19" @default.
• W2170592008 countsByYear W21705920082012 @default.
• W2170592008 countsByYear W21705920082013 @default.
• W2170592008 countsByYear W21705920082014 @default.
• W2170592008 countsByYear W21705920082015 @default.
• W2170592008 countsByYear W21705920082023 @default.
• W2170592008 crossrefType "journal-article" @default.
• W2170592008 hasAuthorship W2170592008A5009567259 @default.
• W2170592008 hasAuthorship W2170592008A5018121191 @default.
• W2170592008 hasAuthorship W2170592008A5036269593 @default.
• W2170592008 hasAuthorship W2170592008A5046009433 @default.
• W2170592008 hasAuthorship W2170592008A5055281543 @default.
• W2170592008 hasAuthorship W2170592008A5062832794 @default.
• W2170592008 hasAuthorship W2170592008A5071725615 @default.
• W2170592008 hasAuthorship W2170592008A5077211924 @default.
• W2170592008 hasAuthorship W2170592008A5078989315 @default.
• W2170592008 hasBestOaLocation W21705920081 @default.
• W2170592008 hasConcept C11772777 @default.
• W2170592008 hasConcept C126322002 @default.
• W2170592008 hasConcept C134018914 @default.
• W2170592008 hasConcept C185592680 @default.
• W2170592008 hasConcept C2778163477 @default.
• W2170592008 hasConcept C2778718757 @default.
• W2170592008 hasConcept C2779620165 @default.
• W2170592008 hasConcept C2779969316 @default.
• W2170592008 hasConcept C2780022283 @default.
• W2170592008 hasConcept C2780072125 @default.
• W2170592008 hasConcept C2781471481 @default.
• W2170592008 hasConcept C43554185 @default.
• W2170592008 hasConcept C62231903 @default.
• W2170592008 hasConcept C62746215 @default.
• W2170592008 hasConcept C71924100 @default.
• W2170592008 hasConcept C8004288 @default.
• W2170592008 hasConcept C8243546 @default.
• W2170592008 hasConcept C86803240 @default.
• W2170592008 hasConcept C96942376 @default.
• W2170592008 hasConceptScore W2170592008C11772777 @default.
• W2170592008 hasConceptScore W2170592008C126322002 @default.
• W2170592008 hasConceptScore W2170592008C134018914 @default.
• W2170592008 hasConceptScore W2170592008C185592680 @default.
• W2170592008 hasConceptScore W2170592008C2778163477 @default.
• W2170592008 hasConceptScore W2170592008C2778718757 @default.
• W2170592008 hasConceptScore W2170592008C2779620165 @default.
• W2170592008 hasConceptScore W2170592008C2779969316 @default.
• W2170592008 hasConceptScore W2170592008C2780022283 @default.
• W2170592008 hasConceptScore W2170592008C2780072125 @default.
• W2170592008 hasConceptScore W2170592008C2781471481 @default.
• W2170592008 hasConceptScore W2170592008C43554185 @default.
• W2170592008 hasConceptScore W2170592008C62231903 @default.
• W2170592008 hasConceptScore W2170592008C62746215 @default.
• W2170592008 hasConceptScore W2170592008C71924100 @default.
• W2170592008 hasConceptScore W2170592008C8004288 @default.
• W2170592008 hasConceptScore W2170592008C8243546 @default.
• W2170592008 hasConceptScore W2170592008C86803240 @default.
• W2170592008 hasConceptScore W2170592008C96942376 @default.
• W2170592008 hasIssue "12" @default.

• next